Biodol
Montpellier, FR · 1 known investors
Biodol Therapeutics is a biotech company developing proprietary FLT3 inhibitors (BDT compounds) at the preclinical stage to treat neuropathic and chronic pain, including opioid-combination indications. It holds a portfolio of patents covering the use of FLT3 inhibitors for pain treatment.
Investors · 1
Frequently asked questions
- What does Biodol do?
- Biodol Therapeutics is a biotech company developing proprietary FLT3 inhibitors (BDT compounds) at the preclinical stage to treat neuropathic and chronic pain, including opioid-combination indications. It holds a portfolio of patents covering the use of FLT3 inhibitors for pain treatment.
- Who are Biodol's investors?
- Biodol's investors include V-Bio Ventures.
- Where is Biodol headquartered?
- Biodol is headquartered in Montpellier, FR.